tyrphostin ag 1024 has been researched along with Glial Cell Tumors in 2 studies
tyrphostin AG 1024: modulates radiosensitivity in human breast cancer cells; also an IGF1 receptor inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Steinbach, JP | 1 |
| Eisenmann, C | 1 |
| Klumpp, A | 1 |
| Weller, M | 1 |
| Carapancea, M | 1 |
| Cosaceanu, D | 1 |
| Budiu, R | 1 |
| Kwiecinska, A | 1 |
| Tataranu, L | 1 |
| Ciubotaru, V | 1 |
| Alexandru, O | 1 |
| Banita, M | 1 |
| Pisoschi, C | 1 |
| Bäcklund, ML | 1 |
| Lewensohn, R | 1 |
| Dricu, A | 1 |
2 other studies available for tyrphostin ag 1024 and Glial Cell Tumors
| Article | Year |
|---|---|
Co-inhibition of epidermal growth factor receptor and type 1 insulin-like growth factor receptor synergistically sensitizes human malignant glioma cells to CD95L-induced apoptosis.
Topics: Apoptosis; Brain Neoplasms; Caspase 8; Caspases; Cell Line, Tumor; Enzyme Inhibitors; ErbB Receptors | 2004 |
Dual targeting of IGF-1R and PDGFR inhibits proliferation in high-grade gliomas cells and induces radiosensitivity in JNK-1 expressing cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Cell Proliferatio | 2007 |